- 收听数
- 0
- 性别
- 保密
- 听众数
- 5
- 最后登录
- 2017-10-29
- QQ
 - UID
- 9039
- 阅读权限
- 20
- 帖子
- 382
- 精华
- 0
- 在线时间
- 266 小时
- 注册时间
- 2014-4-12
- 科研币
- 11
- 速递币
- 1169
- 娱乐币
- 11817
- 文献值
- 6
- 资源值
- 0
- 贡献值
- 1
|
5速递币
| 题名 | Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial | | 链接 | http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(16)30531-9/abstract |
|
|
发表于 2017-1-13 08:53:32
淘帖
收藏
顶
踩
